share_log

華潤醫療:截至二零二四年十二月三十一日止之股份發行人的證券變動月報表

CR MEDICAL: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

HKEX ·  Jan 2 16:59

Summary by Futu AI

華潤醫療控股有限公司於2025年1月2日發布了截至2024年12月31日的證券變動月報表。報告顯示,公司的法定股本和已發行股份數量在本月均未發生變化。具體而言,公司的法定股本維持在760,000港元,由3,040,000,000股每股面值0.00025港元的普通股組成。已發行股份總數保持在1,296,676,516股,其中不包含任何庫存股份。公司在本月內未有涉及股份期權、權證、可換股票據或其他可能導致股份變動的協議或安排。
華潤醫療控股有限公司於2025年1月2日發布了截至2024年12月31日的證券變動月報表。報告顯示,公司的法定股本和已發行股份數量在本月均未發生變化。具體而言,公司的法定股本維持在760,000港元,由3,040,000,000股每股面值0.00025港元的普通股組成。已發行股份總數保持在1,296,676,516股,其中不包含任何庫存股份。公司在本月內未有涉及股份期權、權證、可換股票據或其他可能導致股份變動的協議或安排。
CR MEDICAL Holdings Limited published the monthly report on securities changes as of December 31, 2024, on January 2, 2025. The report shows that the company's authorized share capital and the number of issued shares did not change during this month.Specifically, the company's authorized share capital remains at HKD 760,000, consisting of 3,040,000,000 ordinary shares with a par value of HKD 0.00025 each. The total number of issued shares remains at 1,296,676,516 shares, excluding any treasury shares. The company did not involve any agreements or arrangements related to options, warrants, convertible bonds, or other potential causes of share changes during this month.
CR MEDICAL Holdings Limited published the monthly report on securities changes as of December 31, 2024, on January 2, 2025. The report shows that the company's authorized share capital and the number of issued shares did not change during this month.Specifically, the company's authorized share capital remains at HKD 760,000, consisting of 3,040,000,000 ordinary shares with a par value of HKD 0.00025 each. The total number of issued shares remains at 1,296,676,516 shares, excluding any treasury shares. The company did not involve any agreements or arrangements related to options, warrants, convertible bonds, or other potential causes of share changes during this month.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.